Skip to: Content
Skip to: Site Navigation
Skip to: Search
THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

PREMIUM NEWS ARCHIVE

Recently Updated Reports Reveals the Fundamentals of Pain Therapeutics and Examines the Latest Drugs, Markets and Companies.(Report)

Article from: Cancer Weekly Article date: February 24, 2009

Research and Markets (http://www.researchandmarkets.com/research/edfb6a/pain_therapeutics) has announced the addition of Jain PharmaBiotech's new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering (see also Research and Markets).

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is ...

Read full article   (with a Free Trial at HighBeam Research)
Newser gathers stories from across the web and packs what you need to know into about 120 words. Check out these stories related to your search.
Visit our grid for the latest news.

Related Newser Stories
ANALYSIS

'Experts' Too Often Feeding From Industry Troughs

Press misses, ignores where funds come from

May 8, 08 6:41 PM CDT
(Newser) - Media consumers, beware: that assertive, well-versed, trustworthy "expert" may in fact be an industry shill, Shannon Brownlee and Jeanne Lenzer write on Slate. Journalists across the board, and even some radio hosts, are failing to disclose financial ties to various industries—drug companies being a prime example—fudging the... More »

MORE ABOUT:
drugs • antidepressant • drug companies • journalism • radio advertising • front company • source

NYT Cozied Up
to Spitzer Staff Amid Scandal

Emails reveal friendly exchanges between reporters, sources

Nov 4, 09 1:53 PM CST
(Newser) - The New York Times may have broken the news that Eliot Spitzer had a prostitute problem, but it was awfully nice to Spitzer’s staff amid the scandal. Gawker used New York’s open records law to snag a huge number of emails between reporters and Spitzer’s people,... More »

MORE ABOUT:
journalism • Eliot Spitzer • public relations • Gawker • journalistic ethics • David Paterson • source

FDA OKs Drug
for Kids Despite Justice Probe

Firm wooed docs to illegally prescribe antidepressant: feds

Mar 21, 09 9:42 AM CDT
(Newser) - The FDA has approved an antidepressant called Lexapro for kids, just weeks after the Justice Department accused its maker of marketing it illegally—for kids. Prosecutors say Forest Laboratories for years sweet-talked pediatricians into prescribing Lexapro and the similar Celexa by offering spa visits, event tickets, and fishing trips, even... More »

MORE ABOUT:
FDA • antidepressant • drug companies • children • pediatricians • teenager • kickbacks

Congress
to Probe 'Misleading' Drug Ads

Cholesterol, anemia drugs in spotlight

May 8, 08 3:10 AM CDT
(Newser) - A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug... More »

MORE ABOUT:
drugs • advertising • Merck • drug companies • Pfizer • Johnson and Johnson • congressional Democrats • Lipitor • Bart Stupak • Vytorin • Schering-Plough